The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a ...
Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.
It is no mystery that health care costs and insurance premiums are spiking higher than Americans can afford. Two factors — lack of industry transparency and burdensome government regulations — have ...
WASHINGTON, D.C. / ACCESS Newswire / February 11, 2026 / A new report by Aimed Alliance, international patient advocates, and advocacy organizations, found that due to the United States' unique health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results